SOTIO is a biotechnology company developing a next generation Active Cellular Immunotherapy based on activated dendritic cells for the treatment of cancer and autoimmune diseases. SOTIO continues to develop new therapies to address unmet medical needs using its immunotherapy platform and proprietary cell-based technologies.

Job opportunities

The company is looking for talented, motivated, dynamic employees to join its international team, who will have the opportunity to utilize and further develop their own abilities.

PPF Group expands in the field of biotechnology and immunotherapy

PPF Group has acquired a minority stake in OriBase Pharma, a biotechnology company which specialises in the development of new therapies in